I really do not think BG will require a cap raise - at all. What WOULD eventually require one, I suspect, will be research and product developments to put stuff before the FDA - administering drugs like ibuprofen - which will cost millions and I imagine we won’t be needing to raise money until our share price is many multiples of where we currently sit.
OBJ Price at posting:
1.4¢ Sentiment: Buy Disclosure: Held
(20min delay)